About: Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 2007 (uk) article scientifique publié en 2007 (fr) artículu científicu espublizáu en xunetu de 2007 (ast) scientific article published on 01 July 2007 (en)
publication date	wds:Q80557787-BAB2185D-AB4D-4728-9D0B-6615907C76A7
publication date	2007-07-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q80557787-6B819AF9-D3C6-4ABA-9569-405E791A0320 wds:Q80557787-6B9CA177-899E-4365-BEF1-9EBB7999F694 wds:Q80557787-74826FDE-609E-46DC-87BF-34C3B56E3984 wds:Q80557787-9CE37525-5211-4FBF-BE5A-2D91048AAE77 wds:Q80557787-C24D46E4-2E91-497A-9497-C6BA681F7844 wds:Q80557787-D6A8DF1A-CAE3-4E86-B207-EEF390B7C17F wds:Q80557787-F6CE61F1-1309-4E55-A5D4-CEB72B3AD7DC
author name string	Paramita M Ghosh Thomas J Prihoda Naveen K Krishnegowda Roble Bedolla Dean A Troyer Jeffrey I Kreisberg Shazli N Malik
rdfs:label	Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation (en) Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation (nl)
skos:prefLabel	Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation (en) Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation (nl)
name	Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation (en) Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation (nl)
title	wds:Q80557787-61A2508D-380F-4D67-A9D8-667BD5632FF8
title	Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation (en)
page(s)	wds:Q80557787-2DB20FB5-26EB-4331-A08B-C1973F1FF6F0
page(s)	3860-3867
instance of	wds:Q80557787-EF698335-7B34-4C82-8741-955CFFD9E60E
instance of	scholarly article
main subject	wds:Q80557787-001E1688-EDEE-4816-B4D1-503A4E114E1A
main subject	prostate cancer
PubMed ID	wds:Q80557787-B7BA8F03-1122-45FF-BAFA-E2DFB5D87380
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17606718
PubMed ID	17606718
published in	wds:Q80557787-01686FC7-CF53-40B2-A5AB-AE443D3C7460
published in	Clinical Cancer Research
issue	wds:Q80557787-162A8DF1-98D9-4A9F-83E1-502ED1A5BA75
volume	wds:Q80557787-49E2A32D-B22F-4190-B9A5-361747E29A80
issue	13
volume	13
DOI	wds:Q80557787-05419AF6-B0DB-4A3E-A837-106FC729970A
DOI	http://dx.doi.org/10.1158/1078-0432.CCR-07-0091
DOI	10.1158/1078-0432.CCR-07-0091
describes a project that uses	wds:Q80557787-FCB75776-B537-432F-B36C-64D9874EC5C9
describes a project that uses	immunohistochemistry
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80557787
is cites work of	AKT3 promotes prostate cancer proliferation cells through regulation of Akt, B-Raf, and TSC1/TSC2. Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression. Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-kappaB signalling pathway and prognostic significance in prostate cancer Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway Targeting the PI3-kinase/Akt/mTOR signaling pathway Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells. An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients Relationship between expression and prognostic ability of PTEN, STAT3 and VEGF-C in colorectal cancer Posttranslational modification of the androgen receptor in prostate cancer Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers Modeling prostate cancer in mice: limitations and opportunities Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines Caffeic Acid phenethyl ester as a potential treatment for advanced prostate cancer targeting akt signaling PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1. Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer. A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer Friend or foe: role of E-cadherin in prostate cancer metastasis Association of PTEN expression with biochemical recurrence in prostate cancer: results based on previous reports. Enhanced Sensitivity to Sunitinib by Inhibition of Akt1 Expression in Human Castration-resistant Prostate Cancer PC3 Cells Both In Vitro and In Vivo. A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer PTEN genomic deletion defines favorable prognostic biomarkers in localized prostate cancer: a systematic review and meta-analysis. The association of phosphatase and tensin homolog deleted on chromosome 10 polymorphisms and lifestyle habits with colorectal cancer risk in a Chinese population. PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck Activation of mammalian target of rapamycin signaling pathway markers in minute adenocarcinoma of the prostate. PTEN Loss Promotes Intratumoral Androgen Synthesis and Tumor Microenvironment Remodeling via Aberrant Activation of RUNX2 in Castration-Resistant Prostate Cancer. Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer The activity of the androgen receptor variant AR-V7 is regulated by FOXO1 in a PTEN-PI3K-AKT-dependent way. Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer Loss of PLZF expression in prostate cancer by immunohistochemistry correlates with tumor aggressiveness and metastasis Tumorigenesis role and clinical significance of DJ-1, a negative regulator of PTEN, in supraglottic squamous cell carcinoma Emerging therapeutic approaches in the management of metastatic castration-resistant prostate cancer Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors Castration-resistant prostate cancer: potential targets and therapies. Treatment of castration-resistant prostate cancer: updates on therapeutics targeting the androgen receptor signaling pathway. Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software